RRML - The serum level of the immunomodulatory peptide cathelicidin LL37 and T helper cell type 1 inflammatory response in viral hepatitis B, C, and D
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2020): 1.027

Rejection rate (2020): 75%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- October 2021 -
 
Atellica CH 930 chemistry anal... 13
Cell Cycle Regulatory CCND1 G8... 11
Circulating amino acids as fin... 8
Romanian Review of Laboratory ... 7
COVID-19 associated coagulopat... 7
Insights into Innate Immune Re... 6
VEGF-C and podoplanin, as biom... 6
Evaluation of the impact of Co... 6
Mutations in the KRAS gene as ... 6
Correction factor between two ... 5

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 21(1)/2013 DOI:10.2478/rrlm-2013-0023
XML
TXT

The serum level of the immunomodulatory peptide cathelicidin LL37 and T helper cell type 1 inflammatory response in viral hepatitis B, C, and D

Simona A. Iacob, Eugenia Panaitescu, Diana G. Iacob, Manole Cojocaru


Abstract:

Cathelicidin LL37 is an innate immunity antimicrobial peptide involved in the immune modulation of IFN-γ, the key cytokine of T helper cell type 1 (Th1) response. The role of LL37 in viral hepatitis inflammation is unknown. We assessed the serum variations of LL37 and the Th1 response in hepatitis C virus (HCV), hepatitis B virus (HBV) and hepatitis D virus (HDV) infections. The LL37 level (Elisa detection) and Th1 response (defined by IFN-γ level, CD4+ and CD8+ T cell count) were analyzed in 87 patients: 65 hepatitis patients (34 HCV, 18 HBV, 13 HDV) and 22 healthy controls. The subjects, 33 males/ 54 women aged 20-64 years, were selected at "Matei Bals" Institut, Bucharest, Romania. Hepatitis patients were classified according to viral etiology and viral replication as active cases (detectable viremia) versus negative cases (undetectable viremia). Student T test and Mann Whitney analysis were applied. High levels of LL37 (138.09±88.45ng/ml, p=0.045) and IFN-γ (69.82 pg/ml, p=0.005) were detected in the whole group of hepatitis. Active HCV hepatitis presented a significant increase in LL37 level (155.15±78.84ng/ml, p=0.014) and Th1 response by comparison with inactive HCV hepatitis. Conversely active HBV patients displayed low LL37 levels (76.75ng/ml, p=0.009) and no Th1 dominant response by comparison with inactive B hepatitis. High levels of LL37 up to 171.01±72.08 ng/ml and a moderate Th1 response defined HDV patients. Our results highlights increased levels of the cathelicidin LL37 in all viral hepatitis correlated with a strong and concordant immune response in active HCV hepatitis.

Keywords: Cathelicidine LL37,Th1 response,viral hepatitis

 
  PDF Download full text PDF
(280 KB)
     
 
How to cite
Iacob SA, Panaitescu E, Iacob DG, Cojocaru M. The serum level of the immunomodulatory peptide cathelicidin LL37 and T helper cell type 1 inflammatory response in viral hepatitis B, C, and D. Rev Romana Med Lab. 2013;21(1):101-10. DOI:10.2478/rrlm-2013-0023